Medical terminology is evolving to better reflect actual conditions. Polycystic Ovary Syndrome (PCOS) is now Polyendocrine Metabolic Ovarian Syndrome (PMOS), acknowledging its broader impact beyond cysts. Similarly, Non-Alcoholic Fatty Liver Disease (NAFLD) is now Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). These name changes offer crucial validation and aim to improve diagnosis and treatment for millions.
